Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 220 entries
Sorted by: Best Match Show Resources per page
Darwin's Early Thoughts: Charles Darwin's Notebooks, 1836-1844.

Science (New York, N.Y.)

Montgomery W.
PMID: 17734866
Science. 1988 Jul 15;241(4863):363-5. doi: 10.1126/science.241.4863.363-a.

No abstract available.

Cite
Montgomery W. Darwin's Early Thoughts: Charles Darwin's Notebooks, 1836-1844. Science. 1988;241(4863):363-5doi: 10.1126/science.241.4863.363-a.
Montgomery, W. (1988). Darwin's Early Thoughts: Charles Darwin's Notebooks, 1836-1844. Science (New York, N.Y.), 241(4863), 363-5. https://doi.org/10.1126/science.241.4863.363-a
Montgomery, W. "Darwin's Early Thoughts: Charles Darwin's Notebooks, 1836-1844." Science (New York, N.Y.) vol. 241,4863 (1988): 363-5. doi: https://doi.org/10.1126/science.241.4863.363-a
Montgomery W. Darwin's Early Thoughts: Charles Darwin's Notebooks, 1836-1844. Science. 1988 Jul 15;241(4863):363-5. doi: 10.1126/science.241.4863.363-a. PMID: 17734866.
Copy Download .nbib Format: NLM
Restoration of images possessing a finite Fourier series.

Optics letters

Montgomery WD.
PMID: 19710821
Opt Lett. 1982 Feb 01;7(2):54-6. doi: 10.1364/ol.7.000054.

A standard matrix-inversion method is applied to a problem of image restoration that commonly occurs. The relation of this method to the more powerful methods using von Neumann's alternating-projection theorem or the prolate-spheroidal wave functions is indicated.

Cite
Montgomery WD. Restoration of images possessing a finite Fourier series. Opt Lett. 1982;7(2):54-6doi: 10.1364/ol.7.000054.
Montgomery, W. D. (1982). Restoration of images possessing a finite Fourier series. Optics letters, 7(2), 54-6. https://doi.org/10.1364/ol.7.000054
Montgomery, W D. "Restoration of images possessing a finite Fourier series." Optics letters vol. 7,2 (1982): 54-6. doi: https://doi.org/10.1364/ol.7.000054
Montgomery WD. Restoration of images possessing a finite Fourier series. Opt Lett. 1982 Feb 01;7(2):54-6. doi: 10.1364/ol.7.000054. PMID: 19710821.
Copy Download .nbib Format: NLM
Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence.

Patient preference and adherence

Kelin K, Lambert T, Brnabic AJ, Newton R, Ye W, Escamilla RI, Chen KP, Don L, Montgomery W, Karagianis J, Ascher-Svanum H.
PMID: 21660103
Patient Prefer Adherence. 2011;5:213-22. doi: 10.2147/PPA.S16800. Epub 2011 May 09.

BACKGROUND: This study aimed to improve physicians' understanding of the treatment circumstances and needs of outpatients with schizophrenia at risk of nonadherence, by naturalistically assessing antipsychotic treatment patterns, clinical outcomes, and health care service use in this little-studied patient...

Cite
Kelin K, Lambert T, Brnabic AJ, et al. Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Prefer Adherence. 2011;5:213-22doi: 10.2147/PPA.S16800.
Kelin, K., Lambert, T., Brnabic, A. J., Newton, R., Ye, W., Escamilla, R. I., Chen, K. P., Don, L., Montgomery, W., Karagianis, J., & Ascher-Svanum, H. (2011). Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient preference and adherence, 5213-22. https://doi.org/10.2147/PPA.S16800
Kelin, Katarina, et al. "Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence." Patient preference and adherence vol. 5 (2011): 213-22. doi: https://doi.org/10.2147/PPA.S16800
Kelin K, Lambert T, Brnabic AJ, Newton R, Ye W, Escamilla RI, Chen KP, Don L, Montgomery W, Karagianis J, Ascher-Svanum H. Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Prefer Adherence. 2011;5:213-22. doi: 10.2147/PPA.S16800. Epub 2011 May 09. PMID: 21660103; PMCID: PMC3105874.
Copy Download .nbib Format: NLM
Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?.

Patient preference and adherence

Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM.
PMID: 23818764
Patient Prefer Adherence. 2013 May 27;7:463-70. doi: 10.2147/PPA.S41703. Print 2013.

BACKGROUND: Patients with major depressive disorder (MDD) may suffer from concomitant pain symptoms. The aim of this study is to determine whether the presence of painful physical symptoms (PPS) influences quality of life when taking into account baseline depression...

Cite
Novick D, Montgomery W, Kadziola Z, et al. Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?. Patient Prefer Adherence. 2013;7:463-70doi: 10.2147/PPA.S41703.
Novick, D., Montgomery, W., Kadziola, Z., Moneta, V., Peng, X., Brugnoli, R., & Haro, J. M. (2013). Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?. Patient preference and adherence, 7463-70. https://doi.org/10.2147/PPA.S41703
Novick, Diego, et al. "Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?." Patient preference and adherence vol. 7 (2013): 463-70. doi: https://doi.org/10.2147/PPA.S41703
Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM. Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?. Patient Prefer Adherence. 2013 May 27;7:463-70. doi: 10.2147/PPA.S41703. Print 2013. PMID: 23818764; PMCID: PMC3693583.
Copy Download .nbib Format: NLM
Null curves in diffraction patterns.

Applied optics

Montgomery WD.
PMID: 20168949
Appl Opt. 1977 Sep 01;16(9):2451-3. doi: 10.1364/AO.16.002451.

We show that there is a large class of plane curves which never appear in partial form, as curves along which destructive interference takes place. These curves have an analytic property which, when combined with an analytic property of...

Cite
Montgomery WD. Null curves in diffraction patterns. Appl Opt. 1977;16(9):2451-3doi: 10.1364/AO.16.002451.
Montgomery, W. D. (1977). Null curves in diffraction patterns. Applied optics, 16(9), 2451-3. https://doi.org/10.1364/AO.16.002451
Montgomery, W D. "Null curves in diffraction patterns." Applied optics vol. 16,9 (1977): 2451-3. doi: https://doi.org/10.1364/AO.16.002451
Montgomery WD. Null curves in diffraction patterns. Appl Opt. 1977 Sep 01;16(9):2451-3. doi: 10.1364/AO.16.002451. PMID: 20168949.
Copy Download .nbib Format: NLM
Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.

International journal of general medicine

Ascher-Svanum H, Montgomery WS, McDonnell DP, Coleman KA, Feldman PD.
PMID: 22615534
Int J Gen Med. 2012;5:391-8. doi: 10.2147/IJGM.S29052. Epub 2012 May 04.

BACKGROUND: Little is known about the comparative effectiveness of atypical antipsychotics in long-acting injection formulation. Due to the absence of head-to-head studies comparing olanzapine long-acting injection and risperidone long-acting injection, this study was intended to make exploratory, indirect, cross-study...

Cite
Ascher-Svanum H, Montgomery WS, McDonnell DP, et al. Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons. Int J Gen Med. 2012;5:391-8doi: 10.2147/IJGM.S29052.
Ascher-Svanum, H., Montgomery, W. S., McDonnell, D. P., Coleman, K. A., & Feldman, P. D. (2012). Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons. International journal of general medicine, 5391-8. https://doi.org/10.2147/IJGM.S29052
Ascher-Svanum, Haya, et al. "Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons." International journal of general medicine vol. 5 (2012): 391-8. doi: https://doi.org/10.2147/IJGM.S29052
Ascher-Svanum H, Montgomery WS, McDonnell DP, Coleman KA, Feldman PD. Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons. Int J Gen Med. 2012;5:391-8. doi: 10.2147/IJGM.S29052. Epub 2012 May 04. PMID: 22615534; PMCID: PMC3355848.
Copy Download .nbib Format: NLM
α 2-Adrenoreceptor antagonism may contribute to the atypical properties of risperidone: experimental support for the Nutt case.

Journal of psychopharmacology (Oxford, England)

Herberg LJ, Montgomery AM, Grottick AJ.
PMID: 22297769
J Psychopharmacol. 1995 Jan;9(3):281-3. doi: 10.1177/026988119500900312.

The therapeutic efficacy and reduction in side effects claimed for new antischizophrenic drugs such as clozapine and risperidone have been ascribed to their heightened affinity for serotonin 5-HT(2) receptors rather than D-2 receptors. A case for α(2)-adrenoreceptor antagonism has...

Cite
Herberg LJ, Montgomery AM, Grottick AJ. α 2-Adrenoreceptor antagonism may contribute to the atypical properties of risperidone: experimental support for the Nutt case. J Psychopharmacol. 1995;9(3):281-3doi: 10.1177/026988119500900312.
Herberg, L. J., Montgomery, A. M., & Grottick, A. J. (1995). α 2-Adrenoreceptor antagonism may contribute to the atypical properties of risperidone: experimental support for the Nutt case. Journal of psychopharmacology (Oxford, England), 9(3), 281-3. https://doi.org/10.1177/026988119500900312
Herberg, L J, et al. "α 2-Adrenoreceptor antagonism may contribute to the atypical properties of risperidone: experimental support for the Nutt case." Journal of psychopharmacology (Oxford, England) vol. 9,3 (1995): 281-3. doi: https://doi.org/10.1177/026988119500900312
Herberg LJ, Montgomery AM, Grottick AJ. α 2-Adrenoreceptor antagonism may contribute to the atypical properties of risperidone: experimental support for the Nutt case. J Psychopharmacol. 1995 Jan;9(3):281-3. doi: 10.1177/026988119500900312. PMID: 22297769.
Copy Download .nbib Format: NLM
Enterectomy for Gangrenous Hernia.

British medical journal

Montgomery WP.
PMID: 20758814
Br Med J. 1900 Jan 13;1(2037):72. doi: 10.1136/bmj.1.2037.72.

No abstract available.

Cite
Montgomery WP. Enterectomy for Gangrenous Hernia. Br Med J. 1900;1(2037):72doi: 10.1136/bmj.1.2037.72.
Montgomery, W. P. (1900). Enterectomy for Gangrenous Hernia. British medical journal, 1(2037), 72. https://doi.org/10.1136/bmj.1.2037.72
Montgomery, W P. "Enterectomy for Gangrenous Hernia." British medical journal vol. 1,2037 (1900): 72. doi: https://doi.org/10.1136/bmj.1.2037.72
Montgomery WP. Enterectomy for Gangrenous Hernia. Br Med J. 1900 Jan 13;1(2037):72. doi: 10.1136/bmj.1.2037.72. PMID: 20758814; PMCID: PMC2505551.
Copy Download .nbib Format: NLM
Temporal dynamics of changes in reactive oxygen species (ROS) levels and cellular morphology are coordinated during complementary chromatic acclimation in Fremyella diplosiphon.

Photosynthesis research

Singh SP, Miller HL, Montgomery BL.
PMID: 24122367
Photosynth Res. 2013 Oct 14; doi: 10.1007/s11120-013-9938-7. Epub 2013 Oct 14.

Fremyella diplosiphon alters the phycobiliprotein composition of its light-harvesting complexes, i.e., phycobilisomes, and its cellular morphology in response to changes in the prevalent wavelengths of light in the external environment in a phenomenon known as complementary chromatic acclimation (CCA)....

Cite
Singh SP, Miller HL, Montgomery BL. Temporal dynamics of changes in reactive oxygen species (ROS) levels and cellular morphology are coordinated during complementary chromatic acclimation in Fremyella diplosiphon. Photosynth Res. 2013;doi: 10.1007/s11120-013-9938-7.
Singh, S. P., Miller, H. L., & Montgomery, B. L. (2013). Temporal dynamics of changes in reactive oxygen species (ROS) levels and cellular morphology are coordinated during complementary chromatic acclimation in Fremyella diplosiphon. Photosynthesis research, . https://doi.org/10.1007/s11120-013-9938-7
Singh, Shailendra P, et al. "Temporal dynamics of changes in reactive oxygen species (ROS) levels and cellular morphology are coordinated during complementary chromatic acclimation in Fremyella diplosiphon." Photosynthesis research vol. (2013). doi: https://doi.org/10.1007/s11120-013-9938-7
Singh SP, Miller HL, Montgomery BL. Temporal dynamics of changes in reactive oxygen species (ROS) levels and cellular morphology are coordinated during complementary chromatic acclimation in Fremyella diplosiphon. Photosynth Res. 2013 Oct 14; doi: 10.1007/s11120-013-9938-7. Epub 2013 Oct 14. PMID: 24122367.
Copy Download .nbib Format: NLM
Correlated disorder in two-band models for amorphous semiconductors.

Physical review. B, Condensed matter

Montgomery CG.
PMID: 9935533
Phys Rev B Condens Matter. 1985 May 15;31(10):6525-6530. doi: 10.1103/physrevb.31.6525.

No abstract available.

Cite
Montgomery CG. Correlated disorder in two-band models for amorphous semiconductors. Phys Rev B Condens Matter. 1985;31(10):6525-6530doi: 10.1103/physrevb.31.6525.
Montgomery, C. G. (1985). Correlated disorder in two-band models for amorphous semiconductors. Physical review. B, Condensed matter, 31(10), 6525-6530. https://doi.org/10.1103/physrevb.31.6525
Montgomery. "Correlated disorder in two-band models for amorphous semiconductors." Physical review. B, Condensed matter vol. 31,10 (1985): 6525-6530. doi: https://doi.org/10.1103/physrevb.31.6525
Montgomery CG. Correlated disorder in two-band models for amorphous semiconductors. Phys Rev B Condens Matter. 1985 May 15;31(10):6525-6530. doi: 10.1103/physrevb.31.6525. PMID: 9935533.
Copy Download .nbib Format: NLM
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care.

Open forum infectious diseases

Kamis KF, Marx GE, Scott KA, Gardner EM, Wendel KA, Scott ML, Montgomery AE, Rowan SE.
PMID: 31341933
Open Forum Infect Dis. 2019 Jun 27;6(7):ofz310. doi: 10.1093/ofid/ofz310. eCollection 2019 Jul.

OBJECTIVE: Strategies to increase pre-exposure prophylaxis (PrEP) uptake are needed. We hypothesized that same-day PrEP initiation in a sexually transmitted diseases (STD) clinic would be acceptable, feasible, and safe, and that individuals would engage in ongoing PrEP care.METHOD: Individuals...

Cite
Kamis KF, Marx GE, Scott KA, et al. Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care. Open Forum Infect Dis. 2019;6(7):ofz310doi: 10.1093/ofid/ofz310.
Kamis, K. F., Marx, G. E., Scott, K. A., Gardner, E. M., Wendel, K. A., Scott, M. L., Montgomery, A. E., & Rowan, S. E. (2019). Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care. Open forum infectious diseases, 6(7), ofz310. https://doi.org/10.1093/ofid/ofz310
Kamis, Kevin F, et al. "Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care." Open forum infectious diseases vol. 6,7 (2019): ofz310. doi: https://doi.org/10.1093/ofid/ofz310
Kamis KF, Marx GE, Scott KA, Gardner EM, Wendel KA, Scott ML, Montgomery AE, Rowan SE. Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care. Open Forum Infect Dis. 2019 Jun 27;6(7):ofz310. doi: 10.1093/ofid/ofz310. eCollection 2019 Jul. PMID: 31341933; PMCID: PMC6641790.
Copy Download .nbib Format: NLM
Retraction: Disruption of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Gene in Mice Causes Myelogenous Hyperplasia.

Cancer research

Long DJ, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK.
PMID: 30442815
Cancer Res. 2018 Nov 15;78(22):6526. doi: 10.1158/0008-5472.CAN-18-2455.

No abstract available.

Cite
Long DJ, Gaikwad A, Multani A, et al. Retraction: Disruption of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Gene in Mice Causes Myelogenous Hyperplasia. Cancer Res. 2018;78(22):6526doi: 10.1158/0008-5472.CAN-18-2455.
Long, D. J., Gaikwad, A., Multani, A., Pathak, S., Montgomery, C. A., Gonzalez, F. J., & Jaiswal, A. K. (2018). Retraction: Disruption of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Gene in Mice Causes Myelogenous Hyperplasia. Cancer research, 78(22), 6526. https://doi.org/10.1158/0008-5472.CAN-18-2455
Long, Delwin J, et al. "Retraction: Disruption of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Gene in Mice Causes Myelogenous Hyperplasia." Cancer research vol. 78,22 (2018): 6526. doi: https://doi.org/10.1158/0008-5472.CAN-18-2455
Long DJ, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK. Retraction: Disruption of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Gene in Mice Causes Myelogenous Hyperplasia. Cancer Res. 2018 Nov 15;78(22):6526. doi: 10.1158/0008-5472.CAN-18-2455. PMID: 30442815.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 220 entries